Brandi Galvin Morandi - 17 Feb 2026 Form 4 Insider Report for EQUINIX INC (EQIX)

Role
Chief People Officer
Signature
/s/ Samantha Lagocki, POA
Issuer symbol
EQIX
Transactions as of
17 Feb 2026
Net transactions value
-$1,464,240
Form type
4
Filing time
19 Feb 2026, 16:08:53 UTC
Previous filing
17 Feb 2026
Next filing
13 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MORANDI BRANDI GALVIN Chief People Officer C/O EQUINIX, INC., ONE LAGOON DRIVE, REDWOOD CITY /s/ Samantha Lagocki, POA 19 Feb 2026 0001219928

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EQIX Common Stock Options Exercise $0 +687 +7.6% $0.000000 9,670 17 Feb 2026 Direct F1
transaction EQIX Common Stock Options Exercise $0 +778 +8% $0.000000 10,448 17 Feb 2026 Direct
transaction EQIX Common Stock Options Exercise $0 +1,514 +14% $0.000000 11,962 17 Feb 2026 Direct
transaction EQIX Common Stock Sale $52,836 -57 -0.48% $926.95 11,905 18 Feb 2026 Direct F2, F3
transaction EQIX Common Stock Sale $374,886 -404 -3.4% $927.93 11,501 18 Feb 2026 Direct F2, F4
transaction EQIX Common Stock Sale $136,651 -147 -1.3% $929.60 11,354 18 Feb 2026 Direct F2, F5
transaction EQIX Common Stock Sale $111,654 -120 -1.1% $930.45 11,234 18 Feb 2026 Direct F2, F6
transaction EQIX Common Stock Sale $143,613 -154 -1.4% $932.55 11,080 18 Feb 2026 Direct F2, F7
transaction EQIX Common Stock Sale $80,310 -86 -0.78% $933.83 10,994 18 Feb 2026 Direct F2, F8
transaction EQIX Common Stock Sale $37,454 -40 -0.36% $936.36 10,954 18 Feb 2026 Direct F2
transaction EQIX Common Stock Sale $187,697 -200 -1.8% $938.48 10,754 18 Feb 2026 Direct F2, F9
transaction EQIX Common Stock Sale $75,182 -80 -0.74% $939.78 10,674 18 Feb 2026 Direct F2, F10
transaction EQIX Common Stock Sale $75,324 -80 -0.75% $941.56 10,594 18 Feb 2026 Direct F2, F11
transaction EQIX Common Stock Sale $113,124 -120 -1.1% $942.70 10,474 18 Feb 2026 Direct F2, F12
transaction EQIX Common Stock Sale $75,509 -80 -0.76% $943.86 10,394 18 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQIX Restricted Stock Unit Options Exercise $0 -687 -100% $0.000000 0 17 Feb 2026 Common Stock 687 $0.000000 Direct F13, F14
transaction EQIX Restricted Stock Unit Options Exercise $0 -778 -50% $0.000000 777 17 Feb 2026 Common Stock 778 $0.000000 Direct F14, F15
transaction EQIX Restricted Stock Unit Award $0 +3,027 $0.000000 3,027 17 Feb 2026 Common Stock 3,027 $0.000000 Direct F14, F16
transaction EQIX Restricted Stock Unit Options Exercise $0 -1,514 -50% $0.000000 1,513 17 Feb 2026 Common Stock 1,514 $0.000000 Direct F14, F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 32.243 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 13, 2026.
F2 Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.29 to $927.26, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 12 to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.34 to $928.00 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.31 to $930.31 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.37 to $930.56 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $932.25 to $933.22 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.35 to $934.29 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.00 to $938.91 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $939.47 to $940.08 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.53 to $941.58 inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.60 to $942.89 inclusive.
F13 On February 14, 2023, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2023. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 12, 2024, 25% will vest on February 15, 2025 and the remaining 25% will vest on February 15, 2026, subject solely to continued service.
F14 Restricted stock unit award expires upon reporting person's termination of service.
F15 On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service.
F16 On March 11, 2025 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2025. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2026, 25% will vest on February 15, 2027 and the remaining 25% will vest on February 15, 2028, subject solely to continued service.